Research programme: peripheral benzodiazepine receptor ligands - sanofi-aventis
Latest Information Update: 04 Nov 2017
At a glance
- Originator sanofi-aventis
- Developer Sanofi
- Class
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Neurological disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Neurological-disorders in France
- 08 Mar 2007 Preclinical trials in Neurological disorders in France (unspecified route)